Document is current
Any future updates will be listed below
-
Authors
Nakazawa, Eriko https://orcid.org/0000-0002-2418-5658
Uchimura, Toru https://orcid.org/0009-0000-7057-2475
Ohyama, Rie
Togashi, Hayato https://orcid.org/0000-0002-0235-019X
Inaba, Aya
Shiga, Kentaro https://orcid.org/0000-0001-9482-8690
Ito, Shuichi https://orcid.org/0000-0002-5242-8987
- License Information
-
More Information
Article History
Received: 6 February 2024
Accepted: 31 December 2024
First Online: 17 February 2025
Declarations
:
: Shuichi Ito has received research funding from Asahi Kasei Pharma, Chugai Pharmaceutical Co. Ltd., and Zenyaku Kogyo Co., as well as lecture fees from Astellas Pharma Co., Ltd., Asahi Kasei Pharma, Chugai Pharmaceutical Co. Ltd., Zenyaku Kogyo Co., and Novartis Pharma.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Written informed consent for publication of this case report was obtained from the patients’ parents.
